The role of histopathological examination, therapeutic difficulties and thromboembolism treatment during palliative chemotherapy in patient with antithrombin deficiency , colon cancer and endometrial cancer
Journal Title: OncoReview - Year 2017, Vol 7, Issue 1
Abstract
Palliative chemotherapy in patients with thrombophilia is a challenge for clinical oncologists. On one hand the optimal treatment should be very safe for patient, on the other hand – as effective as possible. That therapy is also connected with proper thromboprophylaxis. The incidence of multiple cancers is a serious problem of modern oncology. In patients whose medical history includes two or more cancers, it is essential to obtain histopathological diagnosis before the administration of treatment of disseminated disease. It allows to avoid improper therapy which is often toxic. The article presents the case of a patient with antithrombin deficiency and two cancers in medical history: colon cancer and endometrial cancer. The treatment of the patient because of the metastatic cancer was started after the histolpathological diagnosis. In metastatic lymph node the endometrial cancer was recognized. The carboplatin and paclitaxel were used in the therapy. The treatment was conducted in four course chemotherapy. It revealed considerable polyneuropathy and hematologic toxicity limiting from further therapy. Treatment allowed to obtain biochemical response, decrease of metastases and the condition of a patient improved. During the systemic therapy thromboprophylaxis with acenocumarol was used. The incidence of venous thromboembolism (VTE) or bleeding complications were not noticed.
Authors and Affiliations
Katarzyna Kryszczyszyn-Musialik, Ludmiła Dolczak, Grzegorz Słomian
Keywords
Related Articles
- EP ID EP187861
- DOI -
- Views 224
- Downloads 0
Myeloma and amyloid
Myocardial dysfunction related to trastuzumab therapy – is effective treatment always possible?
Left ventricle systolic dysfunction manifesting during trastuzumab treatment is defined as cardiotoxicity type II. It is characterized by full reversibility after discontinuation of trastuzumab and cardiological pharmaco...
“Life-saving” inappropriate implantable cardioverter-defibrillator shocks in a cancer patient
Impaired left ventricular ejection fraction (LV EF) in patients with cancer can disqualify them from targeted antineoplastic treatment. We present the case of 63-year-old male with gastric cancer treated palliatively, wi...
Nowe spojrzenie na ocenę skuteczności terapii celowanych zaawansowanego raka nerki– kontrowersje
W ciągu ostatnich kilku lat daje się zaobserwować zdecydowany rozwój nowoczesnych terapii stosowanych w leczeniu zaawansowanego/ rozsianego raka nerki, związany przede wszystkim z poznaniem podstaw molekularnych raka ner...
Receptory PPAR i ich znaczenie w nowotworach
Receptory aktywowane przez proliferatory peroksysomów (ang. peroxisome proliferator activated receptor, PPAR) należą do grupy szeroko rozpowszechnionych sterydowych receptorów jądrowych. Celem pracy było przedstawienie a...